Binex Co., Ltd.
053030 | KO
Overview
Corporate Details
- ISIN(s):
- KR7053030003
- LEI:
- Country:
- South Korea
- Address:
- 부산광역시 사하구 다대로 368-3, 부산광역시
- Website:
- http://www.binex.co.kr/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-08 00:00 |
Regulatory Filings
단일판매ㆍ공급계약체결
|
Korean | 9.5 KB | ||
| 2025-08-27 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.1 KB | ||
| 2025-08-14 00:00 |
Interim / Quarterly Report
반기보고서 (2025.06)
|
Korean | 1.5 MB | ||
| 2025-06-30 00:00 |
Regulatory Filings
단일판매ㆍ공급계약체결
|
Korean | 9.5 KB | ||
| 2025-05-15 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 1.6 MB | ||
| 2025-04-30 00:00 |
Regulatory Filings
소속부변경
|
Korean | 3.6 KB | ||
| 2025-04-18 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 85.9 KB | ||
| 2025-04-07 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 29.4 KB | ||
| 2025-03-24 00:00 |
AGM Information
정기주주총회결과
|
Korean | 23.7 KB | ||
| 2025-03-24 00:00 |
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
|
Korean | 10.2 KB | ||
| 2025-03-14 00:00 |
Audit Report / Information
감사보고서제출
|
Korean | 25.5 KB | ||
| 2025-03-14 00:00 |
Annual Report
사업보고서 (2024.12)
|
Korean | 2.0 MB | ||
| 2025-03-05 00:00 |
Earnings Release
매출액또는손익구조30%(대규모법인은15%)이상변동
|
Korean | 12.1 KB | ||
| 2025-03-05 00:00 |
Pre-Annual General Meeting Information
주주총회소집결의
|
Korean | 13.3 KB | ||
| 2025-03-05 00:00 |
Pre-Annual General Meeting Information
주주총회소집공고
|
Korean | 196.9 KB |
Automate Your Workflow. Get a real-time feed of all Binex Co., Ltd. filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for Binex Co., Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Binex Co., Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
Pioneering RNAi gene-silencing therapies for rare genetic and cardiometabolic diseases.
United States of America
ALNY
United States of America
ALNY
Develops and commercializes novel treatments for neurodegenerative diseases like Alzheimer's and ALS.
United States of America
ACOG
United States of America
ACOG
Manufactures critical reagents for biopharma, scaling from research to GMP manufacturing.
United States of America
TKNO
United States of America
TKNO
Developing therapies for Parkinsonian disorders and MSA by inhibiting protein aggregation.
United States of America
ATHE
United States of America
ATHE
Developing novel peptide therapeutics for obesity, liver, and cardiometabolic diseases.
United States of America
ALT
United States of America
ALT
Developing precision medicines for depression and schizophrenia using a brain biomarker platform.
United States of America
ANRO
United States of America
ANRO
Develops targeted oral therapies for immune-mediated diseases using precision immunology.
United States of America
ALMS
United States of America
ALMS
Develops and manufactures affordable biosimilar medicines for global patient access.
Luxembourg
ALVO
Luxembourg
ALVO
Clinical-stage firm developing CD47 inhibitors for hematologic and solid tumors.
United States of America
ALXO
United States of America
ALXO
Developing lithium & vaccine therapies for neurodegenerative & psychiatric disorders.
United States of America
ALZN
United States of America
ALZN